New monkeypox shot technique to get emergency US approval to extend supply
The US supply of the vaccine Jynneos, developed by Danish firm Bavarian Nordic, cannot meet current demand. However, a new dose-saving method might mean more people can get shots without sacrificing protection.
By Madison Muller With assistance from Jeannie Baumann, bloomberg
US health officials are issuing emergency clearance to a technique for extending the supply of monkeypox vaccine made by Bavarian Nordic A/S amid ongoing shortages.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
